ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Clinical trial NCT03494504 · COMPLETED
Trial details
- NCT number
- NCT03494504
- Sponsor
- Aldeyra Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-30
- Primary completion
- 2018-11-05
- Enrollment
- 318
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.